¼¼°èÀÇ ¹æ»ç¼± Á¾¾çÇÐ ½ÃÀå º¸°í¼­(2025³â)
Radiation Oncology Global Market Report 2025
»óǰÄÚµå : 1751092
¸®¼­Ä¡»ç : The Business Research Company
¹ßÇàÀÏ : On Demand Report
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 175 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,490 £Ü 6,160,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,490 £Ü 8,904,000
PDF (Site License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷ÀåÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,490 £Ü 11,649,000
PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.
¤± º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼Û±âÀÏÀº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

¹æ»ç¼± Á¾¾çÇÐ ½ÃÀå ±Ô¸ð´Â ÇâÈÄ ¸î ³â µ¿¾È °­·ÂÇÑ ¼ºÀå¼¼¸¦ º¸ÀÏ °ÍÀ¸·Î ¿¹»óµÇ¸ç, 2029³â±îÁö ¿¬Æò±Õ ¼ºÀå·ü(CAGR) 9.3%·Î 125¾ï 1,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¿¹Ãø ±â°£ µ¿¾ÈÀÇ ¼ºÀåÀº Á¤¹ÐÄ¡·á¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡, ¿Ü·¡ ¾Ï¼¾ÅÍ È®´ë, Ä¡·á°èȹ ¼ÒÇÁÆ®¿þ¾î äÅà Ȯ´ë, ¾Ï Ä¡·á¿¡ ´ëÇÑ Á¤ºÎ ÀÌ´Ï¼ÅÆ¼ºê Áõ°¡, ÇコÄɾî ÀÎÇÁ¶ó È®´ë µîÀÇ ¿äÀο¡ ±âÀÎÇÑ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù. ÀÌ ±â°£ÀÇ ÁÖ¿ä µ¿ÇâÀ¸·Î´Â ¸ÂÃãÇü Ä¡·á °èȹ, °íÈ­Áú ¿µ»ó, AI žÀç ¿µ»ó, Á¤À§Àû üºÎ ¹æ»ç¼± Ä¡·á(SBRT)ÀÇ ¹ßÀü, ±ÙÁ¢¹æ»ç¼±Ä¡·áÀÇ ¹ßÀü µîÀÌ ÀÖ½À´Ï´Ù.

¾Ï ȯÀÚÀÇ Áõ°¡´Â ÇâÈÄ ¸î ³â µ¿¾È ¹æ»ç¼± Á¾¾çÇÐ ½ÃÀåÀÇ ¼ºÀåÀ» °ßÀÎÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¾ÏÀº ü³» ºñÁ¤»óÀûÀÎ ¼¼Æ÷ÀÇ ÅëÁ¦ÇÒ ¼ö ¾ø´Â Áõ½Ä°ú È®»êÀ» Ư¡À¸·Î Çϸç, ȯÀÚ ¼ö°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Áõ°¡´Â ÁÖ·Î ¾Ï ¹ßº´ À§ÇèÀ» Å©°Ô Áõ°¡½ÃŰ´Â °Ç°­¿¡ ÇØ·Î¿î »ýȰ ½À°üÀÇ º¸±Þ¿¡ ±âÀÎÇÕ´Ï´Ù. ¹æ»ç¼± Á¾¾çÇÐÀº °í¿¡³ÊÁö ¹æ»ç¼±À» ÀÌ¿ëÇÏ¿© ¾Ï¼¼Æ÷¸¦ ÆÄ±«Çϰí, Á¾¾çÀ» Ãà¼ÒÇϰí, Áõ»óÀ» ¿ÏÈ­Çϰí, ¼ö¼úÀ̳ª È­Çпä¹ýÀÇ È¿°ú¸¦ ³ô¿© ¾Ï Ä¡·á¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ÷´Ü ¹æ»ç¼± ±â¼úÀº Á¤È®µµ¿Í Ä¡·á ¼ºÀûÀ» ´õ¿í Çâ»ó½Ã۰í ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, 2024³â 10¿ù ¿µ±¹ Á¤ºÎ ±â°üÀÎ ±¹¹Îº¸°Ç¼­ºñ½º(NHS)´Â 2022³â¿¡ »õ·Î ¾Ï Áø´ÜÀ» ¹ÞÀº ȯÀÚ ¼ö°¡ 34¸¸ 6,217¸íÀ¸·Î ÇÏ·ç Æò±Õ 948¸íÀ̶ó°í º¸°íÇß½À´Ï´Ù. ÀÌ´Â 2021³â 32¸¸ 9,664°Ç¿¡¼­ 5% Áõ°¡ÇÑ ¼öÄ¡ÀÔ´Ï´Ù. °á°úÀûÀ¸·Î ¾Ï ȯÀÚ ¼öÀÇ Áõ°¡°¡ ¹æ»ç¼± Á¾¾çÇÐ ½ÃÀåÀÇ ¼ºÀå¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù.

¹æ»ç¼± Á¾¾çÇÐ ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷µéÀº ´Ù¾çÇÑ ¾Ï Ä¡·á¿¡¼­ Ä¡·á Á¤È®µµ Çâ»ó, ºÎÀÛ¿ë ÃÖ¼ÒÈ­, ȯÀÚ ¿¹ÈÄ °³¼±À» À§ÇØ AI¸¦ Ȱ¿ëÇÑ ¿µ»ó ó¸® ±â¼ú ¹× ÀûÀÀ ±â¼úÀ» ÅëÇÕÇÑ Ã·´Ü ¹æ»ç¼± Ä¡·á ½Ã½ºÅÛ °³¹ß¿¡ ÁÖ·ÂÇϰí ÀÖ½À´Ï´Ù. ¿µ»ó Áø´Ü, Á¶»ç, ¸ð´ÏÅ͸µ µî ¹æ»ç¼± Ä¡·áÀÇ Ãø¸éÀ» °­È­Çϱâ À§ÇØ ÀΰøÁö´É ±â¼úÀ» Ȱ¿ëÇÕ´Ï´Ù. ¿¹¸¦ µé¾î, ½º¿þµ§¿¡ º»»ç¸¦ µÐ ÀÇ·á ±â¼ú ±â¾÷ Elektar´Â 2024³â 5¿ù ¹æ»ç¼± Ä¡·á ±â¼úÀ» °³¼±Çϱâ À§ÇØ °íÈ­ÁúÀÇ AI °­È­ À̹Ì¡À» Ư¡À¸·Î ÇÏ´Â ÃֽŠCT-LinacÀÎ Evo¸¦ ¹ßÇ¥Çß½À´Ï´Ù. ÀÌ ´ÙÀç´Ù´ÉÇÑ ½Ã½ºÅÛÀº ¿ÀÇÁ¶óÀÎ ¹× ¿Â¶óÀÎ ÀûÀÀÇü ¹æ»ç¼± Ä¡·á¿Í ÷´Ü ¿µ»ó À¯µµ ¹æ»ç¼± Ä¡·á¸¦ ¸ðµÎ Áö¿øÇϸç, ÀÓ»óÀǰ¡ ȯÀÚ °³°³Àο¡ ¸Â°Ô Ä¡·á¸¦ ¸ÂÃãÈ­ÇÒ ¶§ ´õ ³ôÀº Á¤È®µµ¿Í À¯¿¬¼ºÀ» Á¦°øÇÕ´Ï´Ù. ÀÌ Çõ½ÅÀº Ä¡·áÀÇ Á¤È®¼º°ú ÀûÀÀ¼ºÀ» ÃÖÀûÈ­ÇÏ¿© ȯÀÚÀÇ ¿¹Èĸ¦ °³¼±ÇÏ´Â °ÍÀ» ¸ñÇ¥·Î ÇÕ´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ½ÃÀå Æ¯Â¡

Á¦3Àå ½ÃÀå µ¿Çâ°ú Àü·«

Á¦4Àå ½ÃÀå - ±Ý¸®, ÀÎÇ÷¹À̼Ç, ÁöÁ¤ÇÐ, ¹«¿ª ÀüÀï°ú °ü¼¼, ±×¸®°í Äڷγª¿Í ȸº¹ÀÌ ½ÃÀå¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» Æ÷ÇÔÇÑ °Å½Ã°æÁ¦ ½Ã³ª¸®¿À

Á¦5Àå ¼¼°èÀÇ ¼ºÀå ºÐ¼®°ú Àü·« ºÐ¼® ÇÁ·¹ÀÓ¿öÅ©

Á¦6Àå ½ÃÀå ¼¼ºÐÈ­

Á¦7Àå Áö¿ªº°¡¤±¹°¡º° ºÐ¼®

Á¦8Àå ¾Æ½Ã¾ÆÅÂÆò¾ç ½ÃÀå

Á¦9Àå Áß±¹ ½ÃÀå

Á¦10Àå Àεµ ½ÃÀå

Á¦11Àå ÀϺ» ½ÃÀå

Á¦12Àå È£ÁÖ ½ÃÀå

Á¦13Àå Àεµ³×½Ã¾Æ ½ÃÀå

Á¦14Àå Çѱ¹ ½ÃÀå

Á¦15Àå ¼­À¯·´ ½ÃÀå

Á¦16Àå ¿µ±¹ ½ÃÀå

Á¦17Àå µ¶ÀÏ ½ÃÀå

Á¦18Àå ÇÁ¶û½º ½ÃÀå

Á¦19Àå ÀÌÅ»¸®¾Æ ½ÃÀå

Á¦20Àå ½ºÆäÀÎ ½ÃÀå

Á¦21Àå µ¿À¯·´ ½ÃÀå

Á¦22Àå ·¯½Ã¾Æ ½ÃÀå

Á¦23Àå ºÏ¹Ì ½ÃÀå

Á¦24Àå ¹Ì±¹ ½ÃÀå

Á¦25Àå ij³ª´Ù ½ÃÀå

Á¦26Àå ³²¹Ì ½ÃÀå

Á¦27Àå ºê¶óÁú ½ÃÀå

Á¦28Àå Áßµ¿ ½ÃÀå

Á¦29Àå ¾ÆÇÁ¸®Ä« ½ÃÀå

Á¦30Àå °æÀï ±¸µµ¿Í ±â¾÷ °³¿ä

Á¦31Àå ±âŸ ÁÖ¿ä ±â¾÷°ú Çõ½ÅÀû ±â¾÷

Á¦32Àå ¼¼°èÀÇ ½ÃÀå °æÀï º¥Ä¡¸¶Å·°ú ´ë½Ãº¸µå

Á¦33Àå ÁÖ¿ä ÀμöÇÕº´

Á¦34Àå ÃÖ±ÙÀÇ ½ÃÀå µ¿Çâ

Á¦35Àå ½ÃÀå ÀáÀç·ÂÀÌ ³ôÀº ±¹°¡, ºÎ¹®, Àü·«

Á¦36Àå ºÎ·Ï

ksm
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Radiation oncology is a specialized field of medicine that uses high-energy radiation to treat cancer by damaging the deoxyribonucleic acid (DNA) of malignant cells, thereby inhibiting their growth and spread. This approach employs advanced techniques to deliver precise treatment, focusing on targeting the affected area while minimizing damage to surrounding healthy tissues.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The primary types of radiation oncology include external beam radiation therapy and internal beam radiation therapy. Internal beam radiation therapy, also known as brachytherapy, involves placing radioactive material directly into or near a tumor to deliver concentrated, localized radiation. It is used in the treatment of various cancers, including prostate, breast, lung, head and neck, colorectal, cervical, gynecological cancers, and others. Key end users of this treatment include hospitals, cancer research institutes, and other healthcare facilities.

The radiation oncology market research report is one of a series of new reports from The Business Research Company that provides radiation oncology market statistics, including radiation oncology industry global market size, regional shares, competitors with a radiation oncology market share, detailed radiation oncology market segments, market trends and opportunities, and any further data you may need to thrive in the radiation oncology industry. This radiation oncology market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The radiation oncology market size has grown strongly in recent years. It will grow from$7.99 billion in 2024 to $8.75 billion in 2025 at a compound annual growth rate (CAGR) of 9.6%. The growth during the historic period can be attributed to factors such as the rising incidence of cancer, increased healthcare spending, growth in healthcare infrastructure investments, an aging population, and a higher prevalence of complex cancer cases.

The radiation oncology market size is expected to see strong growth in the next few years. It will grow to$12.51 billion in 2029 at a compound annual growth rate (CAGR) of 9.3%. The growth during the forecast period can be attributed to factors such as the growing demand for precision treatments, the expansion of outpatient cancer centers, increased adoption of treatment planning software, rising government initiatives in cancer care, and expanding healthcare infrastructure. Key trends during this period include personalized treatment plans, high-definition imaging, AI-powered imaging, advancements in stereotactic body radiation therapy (SBRT), and progress in brachytherapy.

The increasing number of cancer cases is expected to drive the growth of the radiation oncology market in the coming years. Cancer, characterized by the uncontrolled growth and spread of abnormal cells in the body, affects a growing number of patients. This rise is primarily due to the widespread adoption of unhealthy lifestyles that significantly heighten the risk of developing cancer. Radiation oncology helps treat cancer by utilizing high-energy radiation to destroy cancer cells, shrink tumors, alleviate symptoms, and enhance the effectiveness of surgery and chemotherapy. Advanced radiation techniques have further improved precision and outcomes. For example, in October 2024, the National Health Service (NHS), a UK-based government body, reported that there were 346,217 new cancer diagnoses in 2022, averaging 948 per day. This marked a 5% increase from the 329,664 diagnoses in 2021. As a result, the rising number of cancer cases is contributing to the growth of the radiation oncology market.

Leading companies in the radiation oncology market are focusing on developing advanced radiation therapy systems that incorporate AI-powered imaging and adaptive technologies to improve treatment precision, minimize side effects, and enhance patient outcomes for various cancer treatments. AI-powered radiotherapy leverages artificial intelligence technologies to enhance aspects of radiation therapy, including treatment planning, imaging, delivery, and monitoring. For example, in May 2024, Elekta, a Sweden-based medical technology company, introduced Evo, its latest CT-Linac, which features high-definition AI-enhanced imaging designed to refine radiation therapy techniques. This versatile system supports both offline and online adaptive radiation therapy as well as advanced image-guided radiation therapy, offering clinicians greater precision and flexibility in customizing treatments for individual patients. The innovation aims to improve patient outcomes by optimizing the accuracy and adaptability of treatments.

In June 2024, AstraZeneca plc, a UK-based pharmaceutical and biotechnology company, acquired Fusion Pharmaceuticals for an undisclosed sum. With this acquisition, AstraZeneca seeks to strengthen its oncology portfolio by incorporating Fusion's innovative radioconjugate (RC) technology, particularly for enhancing targeted cancer therapies such as FPI-2265 for metastatic castration-resistant prostate cancer (mCRPC). The goal is to advance precision oncology and reduce dependence on traditional treatments. Fusion Pharmaceuticals, a clinical-stage oncology company based in Canada, focuses on developing next-generation radiopharmaceuticals as precision medicines.

Major players in the radiation oncology market are Hitachi Ltd., Siemens Healthineers, Philips Healthcare, GE Healthcare Technologies Inc., Varian Medical Systems, Shimadzu Corporation, Elekta AB, Mirion Technologies, Ion Beam Applications (IBA), Accuray Incorporated, Canon Medical Systems, Eckert & Ziegler BEBIG, ViewRay Inc., MDS Nordion, Mevion Medical Systems, PTW-Freiburg, Toshiba Medical Systems, CivaTech Oncology, ProTom International, Radcal Corporation, and ScandiDos.

North America was the largest region in the radiation oncology market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in radiation oncology report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the radiation oncology market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The radiation oncology market consists of revenues earned by entities by providing services such as tumor board consultations, radiation oncology equipment maintenance, telemedicine consultations, stereotactic radiosurgery (SRS), and image-guided radiation therapy (IGRT). The market value includes the value of related goods sold by the service provider or included within the service offering. The radiation oncology market also includes sales of radiation therapy equipment, treatment planning software, dosimetry systems, radiation protection products, and medical consumables. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Radiation Oncology Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on radiation oncology market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for radiation oncology ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The radiation oncology market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

1) By Internal Beam Radiation Therapy; Brachytherapy; Endocavitary Brachytherapy; Interstitial Brachytherapy; Intraluminal Brachytherapy

2) By External Beam Radiation Therapy; 3D Conformal Radiation Therapy (3DCRT); Intensity-Modulated Radiation Therapy (IMRT); Stereotactic Radiosurgery (SRS); Stereotactic Body Radiation Therapy (SBRT); Image-Guided Radiation Therapy (IGRT)

Table of Contents

1. Executive Summary

2. Radiation Oncology Market Characteristics

3. Radiation Oncology Market Trends And Strategies

4. Radiation Oncology Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Radiation Oncology Growth Analysis And Strategic Analysis Framework

6. Radiation Oncology Market Segmentation

7. Radiation Oncology Market Regional And Country Analysis

8. Asia-Pacific Radiation Oncology Market

9. China Radiation Oncology Market

10. India Radiation Oncology Market

11. Japan Radiation Oncology Market

12. Australia Radiation Oncology Market

13. Indonesia Radiation Oncology Market

14. South Korea Radiation Oncology Market

15. Western Europe Radiation Oncology Market

16. UK Radiation Oncology Market

17. Germany Radiation Oncology Market

18. France Radiation Oncology Market

19. Italy Radiation Oncology Market

20. Spain Radiation Oncology Market

21. Eastern Europe Radiation Oncology Market

22. Russia Radiation Oncology Market

23. North America Radiation Oncology Market

24. USA Radiation Oncology Market

25. Canada Radiation Oncology Market

26. South America Radiation Oncology Market

27. Brazil Radiation Oncology Market

28. Middle East Radiation Oncology Market

29. Africa Radiation Oncology Market

30. Radiation Oncology Market Competitive Landscape And Company Profiles

31. Radiation Oncology Market Other Major And Innovative Companies

32. Global Radiation Oncology Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Radiation Oncology Market

34. Recent Developments In The Radiation Oncology Market

35. Radiation Oncology Market High Potential Countries, Segments and Strategies

36. Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â